AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer
TAIPEI, April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company…
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
April 13, 2026 09:00 ET | Source: Senti Biosciences, Inc. SOUTH SAN…
Segway Powersports to Present Flagship Super Villain SX20T and AT10 W MUD at 139th Canton Fair
GUANGZHOU, China, April 10, 2026 /PRNewswire/ -- Segway Powersports, a global innovator…
Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results
March 20, 2026 13:30 ET | Source: SANUWAVE Health, Inc. EDEN PRAIRIE,…
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026
March 10, 2026 08:05 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
Surgery Partners, Inc. to Present at Upcoming Investor Conference
March 09, 2026 12:04 ET | Source: Surgery Partners, Inc. BRENTWOOD, Tenn.,…
argenx to Present New Data at 2026 AAN Annual Meeting that Continue to Transform Patient Outcomes in MG and CIDP and Build Upon Strength of Pipeline
Positive results from Phase 3 ADAPT OCULUS study show VYVGART’s potential as…
RadNet, Inc. to Present at the Raymond James 47th Annual Institutional Investors Conference on Tuesday, March 3rd, 2026
March 02, 2026 13:16 ET | Source: RadNet, Inc. LOS ANGELES, March…
argenx to Present at TD Cowen 46th Annual Healthcare Conference
February 23, 2026 01:00 ET | Source: argenx SE February 23, 2026Amsterdam,…
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx),…
